Form 4: Arteris Director Sells Shares Under 10b5-1 Plan

Arteris, Inc. Director Antonio J. Viana sold 6,909 shares of common stock for approximately $14.14 per share, executed under a pre-arranged 10b5-1 trading plan.

Summary

• Director Antonio J. Viana of Arteris, Inc. sold 6,909 shares of common stock.
• The sale occurred on August 5, 2025.
• The shares were sold at a weighted average price of $14.1409, with individual transactions ranging from $14.00 to $14.20.
• This transaction was executed pursuant to a Rule 10b5-1 trading plan adopted on June 13, 2024.
• Following the sale, Antonio J. Viana directly holds 20,352 shares and indirectly holds 196,461 shares through the Viana Family Trust.

Sentiment

Score: 5

Explanation: A neutral score. While it is an insider sale, the fact that it is under a 10b5-1 plan adopted well in advance (June 2024 for an August 2025 sale) mitigates the negative signal often associated with insider selling. It is a pre-scheduled liquidity event rather than a reaction to new company developments.

Positives

• The transaction was conducted under a Rule 10b5-1 trading plan, which indicates a pre-scheduled sale for personal financial planning rather than a reaction to new company developments, mitigating potential negative interpretations of insider selling.

Negatives

• Insider selling, even when pre-planned, can sometimes be perceived by the market as a slight reduction in a director's direct equity alignment with the company's performance.

Future Outlook

No forward-looking statements or guidance are provided in this Form 4 filing, which solely reports an insider transaction.

Industry Context

This Form 4 filing reports a routine insider transaction and does not provide information relevant to broader industry trends or competitive dynamics.

Comparison to Industry Standards

• This Form 4 filing reports a standard insider transaction and does not contain information suitable for comparison to industry-specific benchmarks or competitor results.

Stakeholder Impact

• The sale by a director, even under a 10b5-1 plan, slightly reduces insider ownership, which could be viewed by some shareholders as a minor decrease in alignment, though the impact is minimal given the pre-planned nature and remaining substantial holdings.

Key Dates

Recommendation

The filing is a routine Form 4 reporting a pre-scheduled sale by a director under a 10b5-1 plan. Such sales are typically for personal financial planning and do not inherently signal a change in the company's fundamental outlook or performance. Given the transaction is pre-planned and not a reaction to new information, it does not provide a strong basis for a 'buy' or 'sell' recommendation. Investors should focus on the company's operational performance and broader market conditions.

Keywords

Arteris Inc., AIP, Form 4, Insider Trading, Stock Sale, Director, 10b5-1 Plan, Equity Transaction